SCHEMBL222501

SCHEMBL222501

CCOC(=O)c1c(N=Cc2ccc(-c3cccs3)s2)sc(N=Cc2ccc(-c3cccs3)s2)c1C(=O)OCC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 5/20 0.64
ALDH1A1 P00352 7/20 0.50
KDM4E B2RXH2 6/20 0.50
NPSR1 Q6W5P4 6/20 0.50
HPGD P15428 6/20 0.50
MAPT P10636 4/20 0.50
GAA P10253 3/20 0.50
HTT P42858 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
KMT2A Q03164 3/20 0.50
POLB P06746 2/20 0.50
MEN1 O00255 2/20 0.50
USP2 O75604 1/20 0.50
GLA P06280 1/20 0.50
THRB P10828 1/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
ALOX12 P18054 1/20 0.50
CASP1 P29466 1/20 0.50
PPARG P37231 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL222500 1.00 PTPN1 (0.64) PTPN1ALDH1A1KDM4ENPSR1HPGD
SCHEMBL226601 0.97 PTPN1 (0.70) PTPN1ALDH1A1KDM4ENPSR1HPGD
SCHEMBL226602 0.97 PTPN1 (0.70) PTPN1ALDH1A1KDM4ENPSR1HPGD
SCHEMBL12204893 0.93 PTPN1 (0.77) PTPN1ALDH1A1KDM4ENPSR1HPGD
SCHEMBL224026 0.93 PTPN1 (0.77) PTPN1ALDH1A1KDM4ENPSR1HPGD
SCHEMBL2742431 0.93 PTPN1 (0.56) PTPN1ALDH1A1KDM4ENPSR1HPGD
SCHEMBL2742430 0.90 PTPN1 (0.61) PTPN1ALDH1A1KDM4ENPSR1HPGD
SCHEMBL2742429 0.87 PTPN1 (0.53) PTPN1ALDH1A1KDM4ENPSR1HPGD
SCHEMBL12204878 0.87 PTPN1 (0.79) PTPN1ALDH1A1KDM4ENPSR1HPGD
SCHEMBL2742432 0.86 PTPN1 (0.64) PTPN1ALDH1A1KDM4ENPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004386-A1 CONJUGATED THIOPHENES HAVING CONDUCTING PROPERTIES AND SYNTHESIS OF SAME UNIVERSITE DE MONTREAL (CA) 2012-01-05 US disclosed
US-8034895-B2 Conjugated thiophenes having conducting properties and synthesis of same Université de Montréal (CA) 2011-10-11 US disclosed
US-20070287842-A1 Conjugated Thiophenes Having Conducting Properties and Synthesis of Same UNIVERSITE DE MONTREAL (CA) 2007-12-13 US disclosed
WO-2005073265-A1 CONJUGATED THIOPHENES HAVING CONDUCTING PROPERTIES AND SYNTHESIS OF SAME UNIVERSITE DE MONTREAL (CA) 2005-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287842-A1 Conjugated Thiophenes Having Conducting Properties and Synthesis of Same DDT, DDC, TRPA1 PTPN1 945/4885ALDH1A1 91/4885KDM4E 4090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.